VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 87 filers reported holding VAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $56,877,152 | +11.8% | 753,240 | +1.1% | 4.39% | -17.6% |
Q1 2024 | $50,890,950 | -19.2% | 745,000 | -25.7% | 5.33% | -23.6% |
Q4 2023 | $62,951,160 | -5.2% | 1,002,407 | -23.0% | 6.97% | -35.8% |
Q3 2023 | $66,396,709 | +2.3% | 1,302,407 | +0.2% | 10.86% | +21.6% |
Q2 2023 | $64,922,000 | +42.4% | 1,300,000 | +6.8% | 8.93% | +51.7% |
Q1 2023 | $45,605,064 | +35.2% | 1,216,784 | +73.0% | 5.89% | +13.8% |
Q4 2022 | $33,729,996 | +101.2% | 703,441 | +0.7% | 5.17% | +46.4% |
Q3 2022 | $16,767,000 | +6.5% | 698,638 | -3.5% | 3.53% | -12.2% |
Q2 2022 | $15,749,000 | +12.5% | 723,781 | +24.9% | 4.02% | -11.4% |
Q1 2022 | $13,998,000 | +178.2% | 579,640 | +174.1% | 4.54% | +68.9% |
Q4 2021 | $5,031,000 | – | 211,483 | – | 2.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,049,893 | $53,523,545 | 17.09% |
Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $40,429,128 | 16.12% |
Kynam Capital Management, LP | 1,302,407 | $66,396,709 | 10.86% |
RA Capital Management | 7,891,254 | $402,296,129 | 7.92% |
COMMODORE CAPITAL LP | 1,100,000 | $56,078,000 | 6.56% |
GREAT POINT PARTNERS LLC | 531,211 | $27,081,137 | 4.93% |
ACUTA CAPITAL PARTNERS, LLC | 121,022 | $6,169,702 | 4.14% |
Frazier Life Sciences Management, L.P. | 1,164,405 | $59,361,367 | 3.94% |
Novo Holdings A/S | 845,000 | $43,078,100 | 3.18% |
BRAIDWELL LP | 1,619,553 | $82,564,812 | 2.61% |